Showing results (2091-2100 of 27,712) with videos related to

Sort By:
Pageof 2,772
Vaccine|March 6, 2018
Lack of nervous necrosis virus (NNV) neutralizing antibodies in convalescent sevenband grouper Hyporthodus septemfasciatus after NNV infectionHyun Jung Gye, Myung-Joo Oh, Toyohiko Nishizawa
Vaccine|March 6, 2018
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised studyClare L Cutland, Terry Nolan, Scott A Halperin, et al.
Vaccine|December 19, 2017
Conventional influenza vaccines influence the performance of a universal influenza vaccine in miceJanelle Rowell, Chia-Yun Lo, Graeme E Price, et al.
Vaccine|December 19, 2017
An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in childrenKelsey R Florek, Luiza M Campos, Katarina M Braun, et al.
Vaccine|February 17, 2018
Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formatsJeff Sedita, Stefanie Perrella, Matt Morio, et al.
Vaccine|January 22, 2023
Collateral damage from debunking mRNA vaccine misinformationNicole M Krause, Becca Beets, Emily L Howell, et al.
Vaccine|January 19, 2023
Safety of primary immunization using inactivated SARS-CoV-2 vaccine (CoronaVac®) among population aged 3 years and older in a large-scale use: A multi-center open-label study in ChinaHaitao Yang, Zhen Li, Ruizhi Zhang, et al.
Vaccine|January 20, 2023
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022Pedro L Moro, Bicheng Zhang, Carol Ennulat, et al.
Vaccine|January 20, 2023
Development of in ovo-compatible NS1-truncated live attenuated influenza vaccines by modulation of hemagglutinin cleavage and polymerase acidic X frameshifting sitesAmir Ghorbani, John M Ngunjiri, Michael Edward C Abundo, et al.
Vaccine|January 31, 2002
Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicityE Njamkepo, F Rimlinger, S Thiberge, et al.
Pageof 2,772